Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

June 14, 2024 9:00 AM

$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24.GERMANTOWN, MD / ACCESSWIRE / June 14, 2024 / Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to transform the lives of patients with Type 1 and insulin-requiring Type 2...

Read more

Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor

June 14, 2024 8:00 AM

BASEL, SWITZERLAND / ACCESSWIRE / June 14, 2024 / Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, proudly announces the appointment of Virginia Savova, PhD as a strategic and scientific advisor. Scailyte announces Virginia Savova, PhD, as a Strategic and Scientific Advisor Dr. Savova brings strong expertise in computational biology, immunology, and cancer research, with a track record of...

Read more

Elizabeth Fraley, CEO of Kinder Ready, Announces a Customized Summer Learning Program for Early Learners.

June 13, 2024 10:35 PM

In the latest progress, Kinder Ready's CEO, Elizabeth Fraley, launches the Summer Learning Initiative to enhance education skills. The organization's Summer Learning Initiative is aimed at supporting early learners in a variety of areas, including fine motor skills, literacy concepts, guided reading, writing skills, and math concepts. The initiative is led by Elizabeth Fraley, a seasoned Early Childhood Expert and Businesswoman. She focuses on...

Read more

Med-X Announces Registration of the Nature-Cide All-Purpose Commercial Concentrate Product in Mexico

June 13, 2024 3:00 PM

Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that its Nature-Cide All-Purpose Commercial Concentrate product from its flagship Nature-Cide product division has been successfully registered and approved for use in Mexico, addressing an urgent need for all-natural products that can be safely used in sensitive industries such as agriculture and...

Read more

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

June 12, 2024 9:00 AM

Renova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart failure.CARLSBAD, CA & SAN DIEGO, CA / ACCESSWIRE / June 12, 2024 / Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today current and potential future clinical...

Read more

Imbiotechnologies Signs Supply Agreement With Medicus Management

June 12, 2024 8:00 AM

IMBiotechnologies Ltd. ("IMBiotechnologies") is pleased to announce the signing of a supply agreement with Medicus Management, LLC ("Medicus"), a group purchasing organization (GPO) currently supplying twenty office-based laboratory (OBL) and ambulatory surgical center (ASC) clinics focused on minimally-invasive procedures."IMBiotechnologies' Ekobi® microspheres product is truly unique compared to the competitive embolic agents on the market,"...

Read more

GenomesDAO Secures New Investment Round From Pantera Capital and Modular Capital

June 12, 2024 3:00 AM

Biotech company continues to gain momentum in its quest to revolutionize the decentralized genomics market.LONDON, UK / ACCESSWIRE / June 12, 2024 / GenomesDAO, a pioneering biotech company focused on the secure, private, and auditable monetization of genomic data, today announced the successful completion of a new investment round led by Pantera Capital and Modular Capital.Pantera, Modular and GenomesDAO GenomesDAO's flagship product...

Read more

Genflow Biosciences PLC Announces Receipt of Grant Funding

June 12, 2024 2:00 AM

LONDON, UK / ACCESSWIRE / June 12, 2024 / THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC...

Read more

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical Trial Financial Management Platform

June 11, 2024 4:45 PM

Rapid growth and strong partnerships with over 50 innovative biopharma companies power Auxilius's momentum ahead of its latest fundraiseNEW YORK, NY / ACCESSWIRE / June 11, 2024 / Auxilius, the first Clinical Trial Financial Management (CTFM) software which enables life science finance, accounting, and clinical operations teams to automate accounting workflows and improve clinical R&D forecast accuracy, has raised $10M in additional financing,...

Read more

Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts

June 11, 2024 12:00 PM

WEST PALM BEACH, FL / ACCESSWIRE / June 11, 2024 / Next Gen Diagnostics announces its first US laboratory will be opening in Cambridge, Massachusetts, to provide low-cost, fully integrated bacterial sequencing and bioinformatics to US customers and partners. Leveraging the advantages of its NGD100 high throughput microfluidic sequencing sample preparation instrument and automated pathogen bioinformatics systems, NGD offers sequencing combined...

Read more

KeViRx, Inc. Awarded $1.99 Million

June 11, 2024 10:15 AM

Department of Defense grant will advance small molecule technology for acute lung injuryCHARLOTTESVILLE, VA / ACCESSWIRE / June 11, 2024 / KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced today the receipt of $1.99 million in grant funding from the U.S. Department of Defense's Peer Reviewed Medical Research Program. This grant funding will allow KeViRx to advance its first-in-class small molecule platform technology,...

Read more

Biolog Delves Into Characterizing Gut Microbiomes With the Launch of PreBioM Plates

June 11, 2024 5:00 AM

HAYWARD, CA / ACCESSWIRE / June 11, 2024 / Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products and services, is excited to announce the launch of its new PreBioM™ microplate product line for microbiome analysis and organism selection. These microplates are designed to enable phenotypic characterization of individual organisms and communities typically found in the gut microbiome, providing...

Read more

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference

June 10, 2024 9:15 AM

Adolore BioTherapeutics ("Adolore" or the "Company"), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain, today announced that it will present at the Virtual Investor Pitch Conference on June 17, 2024 at 10:00 AM ET. As part of the event, Roelof Rongen, CEO of Adolore, will provide an "elevator pitch" and outline the Company's upcoming milestones. Additionally, investors and...

Read more

Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis

June 10, 2024 8:00 AM

Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology, reports positive results from its Phase 1 clinical trial with TH104, a proprietary transmucosal buccal film embedded with the approved, active compound nalmefene that easily adheres inside of the mouth on the cheek and biodegrades within minutes. Results in...

Read more

Next Gen Diagnostics CEO Paul Rhodes Announces That Dr. Linoj Samuel Has Joined NGD’s Scientific Advisory Board

June 7, 2024 3:00 PM

WEST PALM BEACH, FL / ACCESSWIRE / June 7, 2024 / Next Gen Diagnostics announces that Dr. Linoj Samuel, Division Head of the Clinical Microbiology Laboratory for Henry Ford Health in Detroit Michigan, has joined NGD's Scientific Advisory Board. Dr. Samuel, a national leader in defining best practices for integration of clinical microbiology results to optimally benefit patient care and hospital function, is also the current Chair of the American...

Read more

Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program

June 6, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid misuse, abuse and overdose, today announced the achievement of a critical milestone in its opioid use disorder (OUD) program with the selection of a lead drug candidate to move into Investigational...

Read more

InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy

June 5, 2024 11:00 AM

Partnership addresses biopharmaceutical industry's urgent need for improved in-process and QC testing tools for these rapidly evolving application fieldsBOULDER, CO / ACCESSWIRE / June 5, 2024 / InDevR, Inc., a leader in analytical solutions for vaccine in-process and quality control testing, and Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047) specializing in biological...

Read more

DPH Biologicals Delivers Next Generation Biologicals with Expanded Portfolio Built on Novel Technology Platform

June 4, 2024 9:00 AM

DPH Biologicals, a leading developer and supplier of agricultural biologicals, announced its new Prime platform that uses a patented production process for Bacillus spp., a leading plant growth rhizobacterium, to accelerate the germination of bacteria spores, supporting overall plant development while providing crops with more consistent resilience against heat, drought, and alkaline and saline soil conditions."Historically biologicals have been...

Read more

Data4Cure to Present at the BIO International Convention 2024

June 3, 2024 9:00 PM

WALTHAM, MA / ACCESSWIRE / June 3, 2024 / Data4Cure, a leading biomedical data-to-knowledge company, today announced its upcoming presentation at the BIO International Convention 2024 taking place June 3-6, 2024, in San Diego, California.Data4Cure's CEO Dr. Janusz Dutkowski will present advances in the company's Biomedical Intelligence Cloud platform powered by a continuously updated data-driven knowledge graph of over three billion relations....

Read more

PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation

June 3, 2024 9:00 AM

PharmaNest, a leader in high-resolution, single-fiber quantitative Digital Pathology and Artificial Intelligence, showcases the performance of its FibroNest Ph-FCS digital biomarker for quantifying fibrosis severity and its clinical utility in Phase 2 and Phase 3 studies for patients with Metabolic Associated Steatohepatitis (MASH).PRINCETON, NJ / ACCESSWIRE / June 3, 2024 / PharmaNest Inc., a leader in high-resolution quantitative Digital...

Read more